FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199329529> ?p ?o ?g. }

• W3199329529 endingPage "4656" @default.
• W3199329529 startingPage "4656" @default.
• W3199329529 abstract "Inflammatory breast cancer (IBC) is a rare but aggressive form of breast cancer (BC) in which the (prognostic) role of stromal tumour-infiltrating lymphocytes (sTIL) and the peripheral circulating immune cells in patients with residual disease (RD) after neo-adjuvant chemotherapy (NACT) is not clearly established.To describe the evolution of sTIL and some peripheral inflammation markers (Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio and Lymphocyte-to-monocyte ratio) after NACT in IBC, we retrospectively collected clinicopathological variables for 125 stage III IBC patients. sTILs were scored by three different researchers on an H&E slide of the mastectomy specimen. A cohort of subtype-matched non-IBC breast cancer patients (nIBC) treated with NACT was included for comparison.There was no significant difference in the pre- and posttreatment sTIL scores between IBC and nIBC and in both groups the number of sTIL was significantly lower after NACT. However, the IBC phenotype did correlate with a stronger decrease of sTIL after NACT (OR: 0.25, 95% CI: 0.073-0.76, p = 0.018). The change in the peripheral immune markers was not significantly different between IBC and nIBC. After NACT, 75 patients had residual disease. In this group, a high number of sTIL before NACT (HR: 0.23, 95% CI: 0.05-1.02, p = 0.05) was prognostic for a longer OS, while a low number of sTIL after NACT (HR: 0.33, 95% CI: 0.11-0.98, p = 0.046) and a low residual cancer cellularity (HR: 0.20, 95% CI: 0.08-0.52, p < 0.001) was associated with a longer DFS.IBC is associated with a significantly stronger decrease of sTIL after NACT compared to nIBC. Furthermore, a high number of sTIL after NACT was associated with a worse prognosis in IBC." @default.
• W3199329529 created "2021-09-27" @default.
• W3199329529 creator A5001675207 @default.
• W3199329529 creator A5004737640 @default.
• W3199329529 creator A5011644579 @default.
• W3199329529 creator A5011917700 @default.
• W3199329529 creator A5039300232 @default.
• W3199329529 creator A5048441847 @default.
• W3199329529 creator A5049133404 @default.
• W3199329529 creator A5050572255 @default.
• W3199329529 creator A5052209399 @default.
• W3199329529 creator A5058962962 @default.
• W3199329529 creator A5071632433 @default.
• W3199329529 creator A5077531941 @default.
• W3199329529 creator A5091721810 @default.
• W3199329529 date "2021-09-16" @default.
• W3199329529 modified "2023-10-10" @default.
• W3199329529 title "The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy" @default.
• W3199329529 cites W1586470106 @default.
• W3199329529 cites W1841839849 @default.
• W3199329529 cites W2000272838 @default.
• W3199329529 cites W2022140312 @default.
• W3199329529 cites W2063678417 @default.
• W3199329529 cites W2113334910 @default.
• W3199329529 cites W2114633738 @default.
• W3199329529 cites W2136706908 @default.
• W3199329529 cites W2155802897 @default.
• W3199329529 cites W2163871197 @default.
• W3199329529 cites W2169914436 @default.
• W3199329529 cites W2313168486 @default.
• W3199329529 cites W2435430453 @default.
• W3199329529 cites W2510572197 @default.
• W3199329529 cites W2528841985 @default.
• W3199329529 cites W2557243782 @default.
• W3199329529 cites W2571423414 @default.
• W3199329529 cites W2626331869 @default.
• W3199329529 cites W2742749416 @default.
• W3199329529 cites W2762153201 @default.
• W3199329529 cites W2771978163 @default.
• W3199329529 cites W2799386807 @default.
• W3199329529 cites W2805197306 @default.
• W3199329529 cites W2891209904 @default.
• W3199329529 cites W2896084151 @default.
• W3199329529 cites W2901471644 @default.
• W3199329529 cites W2907566829 @default.
• W3199329529 cites W2909799373 @default.
• W3199329529 cites W2940990787 @default.
• W3199329529 cites W2959185538 @default.
• W3199329529 cites W2973721841 @default.
• W3199329529 cites W3014196977 @default.
• W3199329529 cites W3015679651 @default.
• W3199329529 cites W3069697301 @default.
• W3199329529 cites W3086441583 @default.
• W3199329529 cites W3137034665 @default.
• W3199329529 cites W3164578627 @default.
• W3199329529 doi "https://doi.org/10.3390/cancers13184656" @default.
• W3199329529 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8471511" @default.
• W3199329529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572883" @default.
• W3199329529 hasPublicationYear "2021" @default.
• W3199329529 type Work @default.
• W3199329529 sameAs 3199329529 @default.
• W3199329529 citedByCount "7" @default.
• W3199329529 countsByYear W31993295292022 @default.
• W3199329529 countsByYear W31993295292023 @default.
• W3199329529 crossrefType "journal-article" @default.
• W3199329529 hasAuthorship W3199329529A5001675207 @default.
• W3199329529 hasAuthorship W3199329529A5004737640 @default.
• W3199329529 hasAuthorship W3199329529A5011644579 @default.
• W3199329529 hasAuthorship W3199329529A5011917700 @default.
• W3199329529 hasAuthorship W3199329529A5039300232 @default.
• W3199329529 hasAuthorship W3199329529A5048441847 @default.
• W3199329529 hasAuthorship W3199329529A5049133404 @default.
• W3199329529 hasAuthorship W3199329529A5050572255 @default.
• W3199329529 hasAuthorship W3199329529A5052209399 @default.
• W3199329529 hasAuthorship W3199329529A5058962962 @default.
• W3199329529 hasAuthorship W3199329529A5071632433 @default.
• W3199329529 hasAuthorship W3199329529A5077531941 @default.
• W3199329529 hasAuthorship W3199329529A5091721810 @default.
• W3199329529 hasBestOaLocation W31993295291 @default.
• W3199329529 hasConcept C121608353 @default.
• W3199329529 hasConcept C126322002 @default.
• W3199329529 hasConcept C142724271 @default.
• W3199329529 hasConcept C143998085 @default.
• W3199329529 hasConcept C203014093 @default.
• W3199329529 hasConcept C2776694085 @default.
• W3199329529 hasConcept C2777761686 @default.
• W3199329529 hasConcept C2777863537 @default.
• W3199329529 hasConcept C2780007613 @default.
• W3199329529 hasConcept C2780839634 @default.
• W3199329529 hasConcept C530470458 @default.
• W3199329529 hasConcept C71924100 @default.
• W3199329529 hasConcept C8891405 @default.
• W3199329529 hasConcept C90924648 @default.
• W3199329529 hasConceptScore W3199329529C121608353 @default.
• W3199329529 hasConceptScore W3199329529C126322002 @default.
• W3199329529 hasConceptScore W3199329529C142724271 @default.
• W3199329529 hasConceptScore W3199329529C143998085 @default.
• W3199329529 hasConceptScore W3199329529C203014093 @default.

• next